Axsome Therapeutics, Inc. (AXSM) Balance Sheet Annual

Axsome Therapeutics, Inc.

AXSM (NASDAQ)

(%)

Financials
Axsome Therapeutics, Inc. Balance Sheet Statement Annual

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 12-31	2024 12-31	2023 12-31	2022 12-31	2021 12-31	2020 12-31	2019 12-31	2018 12-31	2017 12-31	2016 12-31	2015 12-31	2014 12-31	2013 12-31
Report Filing:	2026-02-23	2025-02-18	2024-02-23	2023-02-28	2022-03-01	2021-03-01	2020-03-12	2019-03-15	2018-03-07	2017-03-07	2016-03-24	2014-12-31	2013-12-31
Total Current Assets	589	485.1	504.3	245.6	86.52	184	220.4	15.22	35.3	38	49.03	2.74	2.1
Cash and Short Term Investments	322.9	315.4	386.2	200.8	86.47	183.9	220	13.97	34.02	36.62	48.04	2.62	2.09
Cash & Equivalents	322.9	315.4	386.2	200.8	86.47	183.9	220	13.97	34.02	36.62	48.04	2.62	2.09
Short Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Receivables	224.5	142	94.82	37.7	0	0	0	0	0	0	0	0	0
Inventory	27.94	15.73	15.13	4.32	0	0	0	0	0	0	0	0	0
Other Current Assets	13.65	11.98	8.12	2.78	0.045	0.148	0.413	1.25	1.28	1.38	0.997	0.126	0.01
Total Assets	689.8	568.5	588.2	331.5	87.79	186.1	220.5	15.38	35.56	38.21	49.08	2.79	2.1
Total Non-Current Assets	100.8	83.43	83.97	85.83	1.27	2.11	0.17	0.164	0.256	0.214	0.043	0.043	0
Property, Plant and Equipment	20.86	5.97	7.62	1.14	0.944	1.79	0.031	0.052	0.068	0.101	0.017	0	0
Goodwill and Intangible Assets	52.56	58.94	65.33	69.97	0	0	0	0	0	0	0	0	0
Goodwill	12.04	12.04	12.04	10.31	0	0	0	0	0	0	0	0	0
Intangible Assets	40.52	46.89	53.29	59.66	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Assets	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Long Term Assets	27.4	18.53	11.03	14.72	0.323	0.317	0.14	0.112	0.188	0.113	0.027	0.043	0
Total Current Liabilities	378.8	230.1	138.9	96.56	23.07	23.44	24.49	10.82	12.18	7.17	2.63	0.973	4.13
Accounts Payable	65.54	72	40.68	38.6	13.15	13.5	10.94	3.69	3.44	4.08	1.89	0.758	0.159
Notes Payable/Short Term Debt	72.98	3.26	1.27	0.425	0.621	1.22	2.6	3.29	3.27	0.269	0	0.041	3.83
Tax Payables	0	0.96	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue	0	0	0	0	0	0	0	0	2.35	0	0	0.036	0
Other Current Liabilities	240.3	153.9	96.91	57.53	9.3	8.71	10.95	3.84	3.12	2.82	0.74	0.137	0.14
Total Liabilities	601.5	511.5	397.3	221.9	72.15	72.34	41.83	14.44	18.84	16.64	2.63	5.99	4.13
Total Non-Current Liabilities	222.7	281.4	258.4	125.4	49.09	48.9	17.33	3.62	6.66	9.47	0	5.02	0
Total Long Term Debt	168.3	189.7	185.1	94.26	49.09	48.9	17.33	3.62	6.66	9.47	0	4.44	0
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non-Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	27.39	12.24	8.3	0.425	0.621	1.8	0	0	0	0	0	0	0
Other Long Term Liabilities	26.97	79.44	65	30.68	-0.621	-1.8	0	0	0	0	0	0.575	0
Total Equity	88.3	57.02	191	109.6	15.63	113.8	178.7	0.938	16.72	21.57	46.44	-3.2	-2.03
Non-Controlling Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholders' Equity	88.3	57.02	191	109.6	15.63	113.8	178.7	0.938	16.72	21.57	46.44	-3.2	-2.03
Retained Earnings	-1,306	-1,123	-835.6	-596.3	-409.2	-278.8	-175.9	-107.6	-76.58	-47.64	-20.44	-8.23	-2.23
Accumulated Other Earnings	0	0	0	0	0	0	0	0	0	0	0	0	-0.005
Common Stock	0.005	0.005	0.005	0.004	0.004	0.004	0.004	0.003	0.003	0.002	0.002	0.001	0.001
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	0.005
Additional Paid in Capital	1,394	1,180	1,027	705.9	424.8	392.6	354.6	108.5	93.3	69.21	66.88	5.03	0.2
Total Liabilities & Total Equity	689.8	568.5	588.2	331.5	87.79	186.1	220.5	15.38	35.56	38.21	49.08	2.79	2.1
Total Liabilities & Shareholders' Equity	689.8	568.5	588.2	331.5	87.79	186.1	220.5	15.38	35.56	38.21	49.08	2.79	2.1
Total Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Debt	241.3	193	186.4	94.68	49.71	50.12	19.93	6.91	9.93	9.74	0	4.48	3.83
Net Debt	-81.64	-122.4	-199.8	-106.2	-36.76	-133.8	-200	-7.06	-24.09	-26.88	-48.04	1.87	1.74

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Axsome Therapeutics, Inc. Balance Sheet Statement Annual